{"id":"https://openalex.org/W4407699629","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","title":"Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study.","display_name":"Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study.","publication_year":2025,"publication_date":"2025-02-10","ids":{"openalex":"https://openalex.org/W4407699629","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.796"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2025.43.5_suppl.796","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2025.43.5_suppl.796","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2025.43.5_suppl.796","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037969914","display_name":"Dingwei Ye","orcid":"https://orcid.org/0000-0001-7770-9753","observed_orcids":["https://orcid.org/0000-0001-7770-9753"]},"institutions":[{"id":"https://openalex.org/I4210093194","display_name":"Fudan University Shanghai Cancer Center","ror":"https://ror.org/00my25942","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093194"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dingwei Ye","raw_affiliation_strings":["Fudan University Shanghai Cancer Center Hospital, Xuhui, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fudan University Shanghai Cancer Center Hospital, Xuhui, Shanghai, China","institution_ids":["https://openalex.org/I4210093194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110775645","display_name":"Shusuan Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I139660479","display_name":"Central South University","ror":"https://ror.org/00f1zfq44","country_code":"CN","type":"education","lineage":["https://openalex.org/I139660479"]},{"id":"https://openalex.org/I4210115624","display_name":"Hunan Cancer Hospital","ror":"https://ror.org/025020z88","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210115624"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shusuan Jiang","raw_affiliation_strings":["Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China","institution_ids":["https://openalex.org/I139660479","https://openalex.org/I4210115624"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059459840","display_name":"Yuan Fang","orcid":"https://orcid.org/0000-0003-1154-5076","observed_orcids":["https://orcid.org/0000-0003-1154-5076"]},"institutions":[{"id":"https://openalex.org/I158842170","display_name":"Chongqing University","ror":"https://ror.org/023rhb549","country_code":"CN","type":"education","lineage":["https://openalex.org/I158842170"]},{"id":"https://openalex.org/I4210154480","display_name":"Chongqing Cancer Hospital","ror":"https://ror.org/047d8yx24","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154480"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fang Yuan","raw_affiliation_strings":["Department of Urologic Oncology Surgery, Chongqing University Cancer Hospital (Chongqing Cancer Institute and Chongqing Cancer Hospital), Chongqing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urologic Oncology Surgery, Chongqing University Cancer Hospital (Chongqing Cancer Institute and Chongqing Cancer Hospital), Chongqing, China","institution_ids":["https://openalex.org/I158842170","https://openalex.org/I4210154480"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017694336","display_name":"Fangjian Zhou","orcid":"https://orcid.org/0000-0001-6581-8151","observed_orcids":["https://orcid.org/0000-0001-6581-8151"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]},{"id":"https://openalex.org/I4391768007","display_name":"State Key Laboratory of Oncology in South China","ror":"https://ror.org/04dn2ax39","country_code":"CN","type":"facility","lineage":["https://openalex.org/I157773358","https://openalex.org/I4391768007"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fangjian Zhou","raw_affiliation_strings":["Department of Urology Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711","https://openalex.org/I4391768007"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kui Jiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]},{"id":"https://openalex.org/I4210100868","display_name":"Second Affiliated Hospital of Dalian Medical University","ror":"https://ror.org/012f2cn18","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100868"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kui Jiang","raw_affiliation_strings":["Department of Gynecological and Genitourinary Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynecological and Genitourinary Medical Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China","institution_ids":["https://openalex.org/I191996457","https://openalex.org/I4210100868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100363169","display_name":"Xiaoping Zhang","orcid":"https://orcid.org/0000-0003-0995-4989","observed_orcids":["https://orcid.org/0000-0003-0995-4989","https://orcid.org/0000-0002-8687-3800"]},"institutions":[{"id":"https://openalex.org/I4210129222","display_name":"Wuhan Union Hospital","ror":"https://ror.org/0371fqr87","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210129222"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaoping Zhang","raw_affiliation_strings":["Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China","institution_ids":["https://openalex.org/I4210129222","https://openalex.org/I47720641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101998973","display_name":"XingYa Li","orcid":"https://orcid.org/0000-0001-9121-6613","observed_orcids":["https://orcid.org/0000-0001-9121-6613"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"XingYa Li","raw_affiliation_strings":["The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079293274","display_name":"Lasika C. Seneviratne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lasika C. Seneviratne","raw_affiliation_strings":["Department of Hematology/Oncology, Los Angeles Hematology Oncology Medical Group, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Los Angeles Hematology Oncology Medical Group, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058340142","display_name":"Guohua Yu","orcid":"https://orcid.org/0000-0002-3260-3178","observed_orcids":["https://orcid.org/0000-0002-3260-3178"]},"institutions":[{"id":"https://openalex.org/I4210113011","display_name":"Weifang People's Hospital","ror":"https://ror.org/01xd2tj29","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210113011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guohua Yu","raw_affiliation_strings":["Weifang People's Hospital, Weifang, Shandong, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weifang People's Hospital, Weifang, Shandong, China","institution_ids":["https://openalex.org/I4210113011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100709814","display_name":"Mingjun Zhang","orcid":"https://orcid.org/0000-0001-5212-9322","observed_orcids":["https://orcid.org/0000-0001-5212-9322","https://orcid.org/0009-0005-9938-9515"]},"institutions":[{"id":"https://openalex.org/I4210149412","display_name":"Second Affiliated Hospital of Anhui Medical University","ror":"https://ror.org/047aw1y82","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210149412"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mingjun Zhang","raw_affiliation_strings":["Department of Oncology, The Second Hospital of Anhui Medical University, Hefei, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, The Second Hospital of Anhui Medical University, Hefei, China","institution_ids":["https://openalex.org/I4210149412"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shuang Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I2800091995","display_name":"West China Medical Center of Sichuan University","ror":"https://ror.org/040nggs60","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I24185976","https://openalex.org/I2800091995"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuang Zhang","raw_affiliation_strings":["West China Medical Center, Sichuan University, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"West China Medical Center, Sichuan University, Chengdu, China","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I2800091995"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mei Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mei Chen","raw_affiliation_strings":["Oncology, Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029612220","display_name":"Gideon Michael Blumenthal","orcid":"https://orcid.org/0000-0002-1264-129X","observed_orcids":["https://orcid.org/0000-0002-1264-129X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gideon Michael Blumenthal","raw_affiliation_strings":["Oncology, Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054523405","display_name":"Omobolaji Oyekunle Akala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omobolaji Oyekunle Akala","raw_affiliation_strings":["Oncology, Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yaling Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125025","display_name":"Kelun Group (China)","ror":"https://ror.org/02jpsw347","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210125025"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yaling Li","raw_affiliation_strings":["Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, Chengdu, China","institution_ids":["https://openalex.org/I4210125025"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dian Jing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210125025","display_name":"Kelun Group (China)","ror":"https://ror.org/02jpsw347","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210125025"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dian Jing","raw_affiliation_strings":["Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, Chengdu, China","institution_ids":["https://openalex.org/I4210125025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024217435","display_name":"Junyou Ge","orcid":"https://orcid.org/0000-0002-6524-0078","observed_orcids":["https://orcid.org/0000-0002-6524-0078"]},"institutions":[{"id":"https://openalex.org/I4210125025","display_name":"Kelun Group (China)","ror":"https://ror.org/02jpsw347","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210125025"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junyou Ge","raw_affiliation_strings":["Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, Chengdu, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Center, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd, Chengdu, China","institution_ids":["https://openalex.org/I4210125025"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021837905","display_name":"Yanxia Shi","orcid":"https://orcid.org/0000-0002-9658-0032","observed_orcids":["https://orcid.org/0000-0002-9658-0032"]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]},{"id":"https://openalex.org/I4391768007","display_name":"State Key Laboratory of Oncology in South China","ror":"https://ror.org/04dn2ax39","country_code":"CN","type":"facility","lineage":["https://openalex.org/I157773358","https://openalex.org/I4391768007"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanxia Shi","raw_affiliation_strings":["Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China","institution_ids":["https://openalex.org/I4210146711","https://openalex.org/I4391768007"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":18,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"5_suppl","first_page":"796","last_page":"796"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sacituzumab-tirumotecan","display_name":"sacituzumab tirumotecan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9559999704360962},{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.7200000286102295},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.3179999887943268},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.6959999799728394},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7940000295639038},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.5870000123977661},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7789999842643738},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6190000176429749},{"id":"https://openalex.org/keywords/platinum-refractory-disease","display_name":"platinum-refractory disease","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8960850238800049},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.6247725486755371},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5593957901000977},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.5121890902519226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4572153091430664},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4364906847476959},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.2697491943836212}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2025.43.5_suppl.796","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2025.43.5_suppl.796","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2025.43.5_suppl.796","doi":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2025.43.5_suppl.796","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4407699629.pdf","grobid_xml":"https://content.openalex.org/works/W4407699629.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7133244187","https://openalex.org/W4416624692","https://openalex.org/W3157821912","https://openalex.org/W4249160781","https://openalex.org/W4415942578","https://openalex.org/W4401875183","https://openalex.org/W4415940023","https://openalex.org/W3162566036","https://openalex.org/W3032085639","https://openalex.org/W3133927564"],"abstract_inverted_index":{"796":[0],"Background:":[1],"Sacituzumab":[2],"tirumotecan":[3],"(sac-TMT;":[4],"also":[5],"known":[6],"as":[7,125,203,210,433],"MK-2870/SKB264)":[8],"is":[9],"a":[10,15,20,126,193,204,211,341,438],"TROP2":[11],"targeting":[12],"ADC":[13,41],"with":[14,33,38,71,192,315],"hydrolytically":[16],"cleavable":[17],"linker":[18],"and":[19,54,98,145,179,220,237,248,281,443],"topoisomerase":[21],"I":[22],"inhibitor":[23],"payload,":[24],"KL610023":[25],"(average":[26],"drug-to-antibody":[27],"ratio,":[28],"7.4).":[29],"In":[30],"patients":[31],"(pts)":[32],"urothelial":[34],"carcinoma":[35],"(UC),":[36],"treatment":[37,255],"the":[39,62,272,304],"anti-TROP2":[40],"sacituzumab":[42],"govitecan":[43],"led":[44],"to":[45,258,395,399],"treatment-related":[46,288],"grade":[47,263],"\u22653":[48,264],"neutropenia":[49,56],"in":[50,57,69,267,303,313,451],"35%":[51],"of":[52,61,106,128,135,143,162,196,270,276,434,449],"pts":[53,70,86,111,131,183,200,225,314,441,450],"febrile":[55],"10%.":[58],"Cohort":[59],"9":[60],"MK-2870-001":[63],"(KL264-01;":[64],"NCT04152499)":[65],"evaluated":[66],"sac-TMT":[67,152,202,209,307],"monotherapy":[68,308],"unresectable,":[72],"locally":[73,95],"advanced/metastatic":[74,96],"UC":[75,317,330,335],"who":[76,318],"progressed":[77,132,319],"on":[78,102,320,447,456],"or":[79,92,160,213,431],"after":[80],"prior":[81,104,117,120],"anti-cancer":[82],"treatments.":[83],"Methods:":[84],"Eligible":[85],"were":[87,112,184,226,278,290],"\u226518":[88],"y,":[89,222],"had":[90,99,253,309],"histologically":[91],"cytologically":[93],"confirmed":[94],"UC,":[97],"experienced":[100],"PD":[101,259,372],"\u22651":[103],"line":[105,127],"platinum-based":[107,322],"therapy.":[108,323],"Platinum":[109],"ineligible":[110],"eligible":[113],"if":[114,130],"they":[115],"received":[116,151,201,208],"anti-PD-(L)1":[118],"therapy;":[119],"neoadjuvant/adjuvant":[121],"therapy":[122,129],"was":[123,166,218,232],"counted":[124],"\u226412":[133],"mo":[134,234,239],"last":[136,435],"dose.":[137],"Pts":[138,150],"must":[139],"have":[140],"ECOG":[141],"PS":[142],"\u22641":[144],"measurable":[146],"disease":[147,430,436],"by":[148,171,186,292],"CT/MRI.":[149],"5":[153,332,337,344],"mg/kg":[154,333],"Q2W":[155],"until":[156],"PD,":[157],"unacceptable":[158],"toxicity,":[159],"withdrawal":[161],"consent.":[163],"Primary":[164],"objective":[165],"ORR":[167,340],"per":[168],"RECIST":[169],"v1.1":[170],"investigator.":[172],"Secondary":[173],"objectives":[174],"included":[175],"DOR,":[176],"PFS,":[177],"OS,":[178],"safety.":[180],"Results:":[181],"49":[182],"treated":[185],"data":[187,244,294],"cutoff":[188,295],"(Jun":[189],"30,":[190],"2024)":[191],"minimum":[194],"follow-up":[195,231],"\u22659":[197],"wk":[198],"(11":[199],"second-line":[205],"treatment;":[206],"38":[207],"third-line":[212],"later":[214],"treatment).":[215],"Median":[216,230,387,401,412],"age":[217],"62":[219],"61":[221],"respectively;":[223],"most":[224,273],"Asian":[227],"(81.8%;":[228],"100%).":[229],"9.5":[233],"(range,":[235,240],"7.5\u201316.2)":[236],"11.7":[238],"7.8\u201317.4),":[241],"respectively.":[242],"By":[243],"cutoff,":[245],"7":[246],"(63.6%)":[247],"29":[249],"(76.3%)":[250],"pts,":[251,271],"respectively,":[252],"discontinued":[254],"mostly":[256],"due":[257],"(45.5%;":[260],"55.3%).":[261],"Treatment-related":[262],"AEs":[265],"occurred":[266],"29/49":[268],"(59.2%)":[269],"common":[274],"(\u226520%)":[275],"which":[277],"anemia":[279],"(38.8%)":[280],"decreased":[282],"neutrophil":[283],"count":[284],"(28.6":[285],"%).":[286],"No":[287],"deaths":[289],"reported":[291],"safety":[293],"(May":[296],"21,":[297],"2024).":[298],"Efficacy":[299],"outcomes":[300],"are":[301,445],"shown":[302],"Table.":[305],"Conclusions:":[306],"promising":[310],"antitumor":[311],"activity":[312],"advanced":[316],"1L":[321],"Clinical":[324],"trial":[325],"information:":[326],"NCT04152499":[327],".":[328],"Outcome":[329],"2Lsac-TMT":[331],"(n=11)":[334],"3L+sac-TMT":[336],"mg/kg(n=38)":[338],"Confirmed":[339],"n":[342,353,359,366,373,381],"(%)":[343,354,360,367,374,382],"(45.5)":[345],"10":[346,363,377],"(26.3)":[347,364,378],"95%":[348],"CI":[349],"16.7\u201376.6":[350],"13.4\u201343.1":[351],"CR":[352],"1":[355,383,385],"(9.1)":[356,384],"0":[357],"PR":[358],"4":[361],"(36.4)":[362],"SD":[365],"3":[368],"(27.3)":[369],"17":[370],"(44.7)":[371],"2":[375],"(18.2)":[376],"Not":[379],"evaluable":[380],"(2.6)":[386],"DOR":[388],"b":[389,403,414,454],",":[390,404,415],"months":[391,405,416],"(range)":[392],"NE":[393,397,419],"(3.48+":[394],"13.86+)":[396],"(2.10":[398],"14.95+)":[400],"PFS":[402],"(95%":[406,417],"CI)":[407,418],"5.78":[408],"(1.68\u2013NE)":[409],"5.03":[410],"(3.52\u20137.39)":[411],"OS":[413],"(2.0\u2013NE)":[420],"11.5":[421],"(8.9\u2013NE)":[422],"NE,":[423],"not":[424],"evaluable.":[425],"\u201c+\u201d":[426],"indicates":[427],"no":[428],"progressive":[429],"death":[432],"assessment.":[437],"Includes":[439],"all":[440],"as-treated,":[442],"percentages":[444],"based":[446],"number":[448],"each":[452],"subgroup.":[453],"Based":[455],"Kaplan-Meier":[457],"method":[458],"for":[459],"censored":[460],"data.":[461]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":9}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-02-19T00:00:00"}